Michael Sheaff

7.2k citations

98 papers · 2.7k indexed · h-index 28

Impact in

Biotechnology top 1%
- Cancer Research and Treatments
Nephrology top 2%
- Acute Kidney Injury Research

Papers in ⓘ

Biotechnology 19
- Cancer Research and Treatments 19
Transplantation 5

Co-authors: Peter W. Szlosarek (14 shared papers)Stavros N Georgiannos (3 shared papers)Melissa Phillips (9 shared papers)Jeremy Steele (18 shared papers)Muhammad M. Yaqoob (8 shared papers)A W Goode (2 shared papers)Martin Raftery (3 shared papers)Robin Rudd (10 shared papers)
Journals: Journal of Clinical Oncology (7 papers)Lung Cancer (7 papers)Kidney International (4 papers)Journal of Clinical Pathology (3 papers)Clinical Infectious Diseases (2 papers)
Partner nations: United Kingdom United States Ireland

In The Last Decade

Michael Sheaff

90 papers receiving 2.7k citations

Peers

Countries citing papers authored by Michael Sheaff

Since Specialization

Citations

This map shows the geographic impact of Michael Sheaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sheaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sheaff more than expected).

Fields of papers citing papers by Michael Sheaff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sheaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sheaff. The network helps show where Michael Sheaff may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Sheaff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Sheaff Line = papers co-authored together Michael Sheaff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Erythropoietin Protects the Kidney against the Injury and Dysfunction Caused by Ischemia-Reperfusion Journal of the American Society of Nephrology ·Edward Sharples, Nimesh S. A. Patel, Paul Aj. Brown, Stewart Keith, Hélder Mota‐Filipe, Michael Sheaff, Julius Kieswich, D. A. Allen, Steven Harwood, Martin Raftery, Christoph Thiemermann, Muhammad M. Yaqoob	2004	331
2	Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges Cancer Research and Treatment ·Melissa Phillips, Michael Sheaff, Peter W. Szlosarek	2013	168
3	Secondary neoplasms of the breast Cancer ·Stavros N Georgiannos, Jo-Anne Chin Aleong, A W Goode, Michael Sheaff	2001	154
4	In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion Clinical Cancer Research ·Peter W. Szlosarek, Astero Klabatsa, A. Pallaska, Michael Sheaff, Paul Smith, Tim Crook, Matthew J. Grimshaw, Jeremy Steele, Robin Rudd, Frances R. Balkwill, Dean A. Fennell	2006	150
5	The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma Lung Cancer ·Justin Stebbing, Thomas Powles, Kirsty McPherson, Jonathan Shamash, Paula Wells, Michael Sheaff, Sarah Slater, Robin Rudd, Dean A. Fennell, Jeremy Steele	2008	108
6	Clinicopathologic features of skin cancer in organ transplant recipients: A retrospective case-control series Journal of the American Academy of Dermatology ·Catherine Harwood, Charlotte M. Proby, Jane McGregor, Michael Sheaff, Irene M. Leigh, R. Cerio	2006	104
7	Statistical Validation of the EORTC Prognostic Model for Malignant Pleural Mesothelioma Based on Three Consecutive Phase II Trials Journal of Clinical Oncology ·Dean A. Fennell, Amit Parmar, Jonathan Shamash, Marie T. Evans, Michael Sheaff, Richard Sylvester, Kevin Dhaliwal, Nicole H. Gower, Jeremy Steele, Robin Rudd	2004	91
8	Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers Journal of Clinical Oncology ·Emma Beddowes, James Spicer, Pui Ying Chan, Ramsay S. Khadeir, Javier Garciá Corbacho, Dimitra Repana, Jeremy Steele, Peter Schmid, Teresa Szyszko, Gary Cook, Monica Diaz, Xiaoxing Feng, Amanda Johnston, J. A. Thomson, Michael Sheaff, Bor-Wen Wu, John S. Bomalaski, Simon Pacey, Peter W. Szlosarek	2017	89
9	Performance of anal cytology in a clinical setting when measured against histology and high-resolution anoscopy findings AIDS ·Mayura Nathan, Naveena Singh, Nigel Garrett, Nicola Hickey, Teresa C. Prevost, Michael Sheaff	2010	88
10	Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor Kidney International ·Sina M. Coldewey, Areeg I. Khan, Amar Kapoor, Massimo Collino, Mara Rogazzo, Michael Brines, Anthony Cerami, Peter A. Hall, Michael Sheaff, Julius Kieswich, Muhammed M. Yaqoob, Nimesh S. A. Patel, Christoph Thiemermann	2013	66
11	Sarcoid tubulo-interstitial nephritis: Long-term outcome and response to corticosteroid therapy Kidney International ·Ravindra Rajakariar, Edward Sharples, Martin Raftery, Michael Sheaff, Muhammad M. Yaqoob	2006	65
12	The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators Surgery ·Stavros N Georgiannos, Andrew Renaut, A W Goode, Michael Sheaff	2003	60
13	Principles And Practice Of Surgical Pathology And Cytopathology. Journal of Clinical Pathology ·Michael Sheaff	1998	59
14	High Pre‐Transplant Soluble CD30 Levels are Predictive of the Grade of Rejection American Journal of Transplantation ·Ravindra Rajakariar, Naina Jivanji, Mira Varagunam, M. Rafiq, Arun Gupta, Michael Sheaff, Paul J. Sinnott, MM Yaqoob	2005	53
15	CAR T-cell immunotherapy of MET-expressing malignant mesothelioma OncoImmunology ·Thivyan Thayaparan, Roseanna M. Petrovic, Daniela Achkova, Tomasz Zabinski, David M. Davies, Astero Klampatsa, Ana C. Parente‐Pereira, Lynsey M. Whilding, Sjoukje JC van der Stegen, Natalie Woodman, Michael Sheaff, Jennifer R. Cochran, James Spicer, John Maher	2017	52
16	Primitive Neuroectodermal Tumor of the Kidney Confirmed by Fluorescence In Situ Hybridization The American Journal of Surgical Pathology ·Michael Sheaff, Aidan McManus, Irene Scheimberg, A. M. I. PARIS, Janet Shipley, Suhail Baithun	1997	51
17	Chinese herbal uropathy and nephropathy The Lancet ·Chris Laing, Sally Hamour, Michael Sheaff, Ron A. Miller, Robin G. Woolfson	2006	51
18	Metabolic Response to Pegylated Arginine Deiminase in Mesothelioma With Promoter Methylation of Argininosuccinate Synthetase Journal of Clinical Oncology ·Peter W. Szlosarek, Phuong Luong, Melissa Phillips, Marina Baccarini, Stephen Ellis, Teresa Szyszko, Michael Sheaff, Norbert Avril	2013	51
19	Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM) Lung Cancer ·Astero Klabatsa, Michael Sheaff, Jeremy Steele, Marie T. Evans, R.M. Rudd, Dean A. Fennell	2005	48
20	Angiosarcoma of the breast: a 30 year perspective with an optimistic outlook British Journal of Plastic Surgery ·Stavros N Georgiannos, Michael Sheaff	2003	43

About Michael Sheaff

Michael Sheaff is a scholar working on Biotechnology, Transplantation, Nephrology, Pulmonary and Respiratory Medicine and Neurology, having authored 98 papers that have together received 2.7k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (20 papers), Cancer Research and Treatments (19 papers), Pleural and Pulmonary Diseases (9 papers), Neuroblastoma Research and Treatments (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Cervical Cancer and HPV Research (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Biotechnology (382 citations), Nephrology (264 citations), Hematology (321 citations), Transplantation (77 citations) and Pulmonary and Respiratory Medicine (891 citations). Michael Sheaff has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Peter W. Szlosarek, Stavros N Georgiannos, Melissa Phillips, Jeremy Steele, Muhammad M. Yaqoob, A W Goode, Martin Raftery, Robin Rudd, Jo-Anne Chin Aleong and Edward Sharples. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Kidney International, Journal of Clinical Pathology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact